• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

Dividend Downfalls: Amazon

Amazon stocks have surged by 170% over the last five years. In the beginning, Amazon was just a marketplace, but now it has a very diverse business ranging from a streaming service, Amazon Prime Video, to Cloud Amazon Web Services (AWS). Moreover, it would be absolutely wrong to only consider  Amazon as a marketplace. The AWS segment of the company alone may count for over $1.4 trillion, which is currently the overall Amazon market cap.

AMZN stocks have lost 25% since the beginning of 2022 due to the disruption of supply chains and a very strong U.S. Dollar. Q2 2022 revenues of Amazon only rose by 7% year-on-year to $121.2 billion, while operating income dropped by 57% year-on-year to $3.3 billion. Over the last 12 months the company has increased its capital spending and, therefore, its net cash flow has gone down from $4.2 billion to -$26.1 billion.

AWS net sales jumped by 33% year-on-year to $19.7 billion in the Q2 2022, while sector operational income rose by 36% year-on-year to $5.7 billion. The net margin of Amazon.com is close to 10% amid a widening cooperation with third-party sellers, but the AWS net margin has already jumped to 30% and may grow to 40% soon. Cloud segment revenues not only compensated for the slowdown of retail sales, but allowed for the invest in new segments like Zoox autonomous vehicles. 


5267
Dividend Aristocrats: Walmart

The dividends of the Walmart, one of the world’s largest retail corporation with a huge chain of hypermarkets, are growing for the last 49 years. The company develops its own e-commerce segment to resist the pressure from on-line retail market players. This development is suggested to be a key driver for Walmart’s growing business. Walmart+ clients would also be granted an access to Paramount+ streaming service.

Walmart Q2 2022 net sales rose by 8.2% year-on-year. On-line sales were up by 12%, which is a pretty good result given the last-year COVID-19 restrictions that boosted on-line sales in 2021. The company has spent $3.1 billion on dividends and $5.7 billion on buybacks in the first half of 2022. 

Walmart stocks are considered a safe haven asset. The demand for company’s services is intact despite negative economic developments, prompting investors’ interest. WMT stock prices are 6% down from the beginning of 2022.


3479
Dividend Aristocrats: Johnson & Johnson

Johnson & Johnson was founded in 1886, and since the last 60 years is constantly raising its dividends. The company has a truly diversified business with three major segments: Consumer health, Pharmaceutical, Medical Devices.

The recent Q2 2022 earnings report was impressive despite consumer market tightening. The revenue grew by 3% year-on-year to $24 billion, while the net free cash flows rose to $8.1 billion over the first half of 2022. Dividend and buybacks were at $5.8 billion and at $2.6 billion respectively. Consumer health segment rose by 3% year-on-year amid elevated demand for analgesics and upper airways medicine. Skin Care Neutrogena brand significantly contributed to the segment earnings. Pharmaceutical sales were up by 12% year-on-year mainly on rising cancer treatment medicine, Grohn’s disease drugs, precox treatment and some other diseases. The COVID-19 vaccine is not expected to make a significant contribution to the segment. Medical Devices segment was up by 3% year-on-year on elevated demand for surgical systems and electrophysiology equipment. Diversified business and vas cash flows are magnetizing investors worldwide, especially now as JNJ stock prices are 7% below the beginning of 2022.


4419
Dividend Aristocrats: Procter & Gamble

Procter & Gamble is constantly increasing its dividends for the last 66 years, which is an astonishing record even among famous U.S. corporations that are operating across the globe. The company has a 200 year track record. Investments in such sustainable reputable companies like Procter & Gamble are looking logical in a turmoil periods.

PG share prices declined by 13% from the beginning of 2022 compared to 16% drop of S&P 500 broad market index. Nobody doubt the company’s shares will recover, as prices dropped only in a connection of the market sentiment, but a not financials of the company itself. Despite stronger U.S. Dollar and rising energy prices net sales of PG rose by 5% to $80.2 billion in 2022. The company spent $10 billion on the buyback and $8.8 billion ion dividends in 2021.

Management of the company provides an optimistic forward guidance for the 2023 with 3-4% growth of sales and EPS up by 4%. Buyback program would be continued with $ 6-8 billion reserved for it while dividend payouts would be raised to $9 billion. Such guidance together with a discount share prices by 14% create excellent buy opportunities for investors.


4097
344

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors